WO/2014/199367 A SYSTEM AND METHODS THEREOF FOR GENERATING IMAGES STREAMS RESPECTIVE OF A VIDEO CONTENT||WO||18.12.2014|
||PCT/IL2014/050380||ANI-VIEW LTD.||MELENBOIM, Tal|
A system is configured to generate imagized video clip respective of a video clip. The system receives electronically at least one video clip. The system analyzes the video clip and generates a plurality of images respective thereto. The system is then configured to generate an imagized video clip respective of the plurality of images. The system is further configured to display the imagized video clip in a sequence at certain timing, thereby providing an output of a video clip respective of the imagized video clip.
WO/2014/120981 COMBINATION FORMULATION OF TWO ANTIVIRAL COMPOUNDS||WO||07.08.2014|
||PCT/US2014/013953||GILEAD PHARMASSET LLC||CHAL, Ben|
Disclosed are pharmaceutical compositions having an effective amount of substantially amorphous ledipasvir and an effective amount of substantially crystalline sofosbuvir.
WO/2014/101970 A METHOD FOR VEHICLE IDENTIFICATION AND A SYSTEM FOR VEHICLE IDENTIFICATION||WO||03.07.2014|
||PCT/EP2012/077109||INSTYTUT BADAWCZY DROG I MOSTOW||KARKOWSKI, Michal|
A method for vehicle identification to determine at least one vehicle characteristic, comprising: obtaining an input image (301) of the vehicle from an image source (101); normalisation of the input image (301 ) of the vehicle in a normalisation unit (103, 104) to obtain a normalized image; determining the vehicle characteristic in a classification unit (111, 112) by comparing parameters of a normalised image obtained in a parametrisation unit (107, 108) with parameters of reference images obtained from a reference database (113, 114). Normalisation in the normalisation unit (103, 104) comprises the steps of: detecting a registration plate area (303) within the input image (301); processing the input image (301) basing on normalisation attributes defining at least one scaling coefficient (znorm, anorm, vnorm); choosing from the scaled image (307) a Rol area (308) of a normalised size and location dependent on the location of the registration plate area (303); and presenting data from the Rol area (308) as a normalised image (311).
WO/2014/105708 METHOD AND APPARATUS FOR NON-NATIVE SHORT MESSAGE SERVICE COMMUNICATIONS||WO||03.07.2014|
||PCT/US2013/076979||VONAGE NETWORK LLC||FIGHEL, Guy|
Methods and apparatus for routing non-native Short Message Service (SMS) messages to a first device, the first device being assigned a native identifier and being associated with a native telephony service provider, are provided herein. In some embodiments, the method includes receiving an SMS message directed to the native identifier of the first device, determining routing instructions for the SMS message based on the native network identifier associated with the first device, and routing the SMS message to the first device based on the determined routing instructions, wherein the act of routing results in SMS messages directed to the native identifier of the first device being directed to a forwarding identifier assigned to the first device by a first non-native communication service provider.
WO/2014/097721 ASCORBIC ACID DERIVATIVE COMPOSITION AND METHOD FOR PRODUCING SAME, ASCORBIC ACID DERIVATIVE SOLUTION, AND EXTERNAL PREPARATION FOR SKIN||WO||26.06.2014|
||PCT/JP2013/077784||SHOWA DENKO K.K.||NAKAMURA Keiichi|
The ascorbic acid derivative composition according to the first embodiment of the present invention comprises a salt of a compound (1) represented by general formula (1) and a salt of a compound (2) represented by general formula (2), and is characterized in that the proportion of the salt of the compound (2) in relation to the total amount of the salt of the compound (1) and the salt of the compound (2) is 0.1-10 mass%. (In the formula, R1 represents a C6-20 straight-chain or branched alkyl group, R2 represents a C6-20 straight-chain or branched alkyl group, and R1 and R2 may be identical to or different from one another.)
WO/2014/090418 CRYOGENIC DEVICE||WO||19.06.2014|
||PCT/EP2013/061068||SHUPPO, Vladimir||SHUPPO, Vladimir|
Cryogenic device for carrying out cryotherapy on the entire body of a patient, the cryogenic device comprising: a treatment cabin (1) for taking up a patient, the treatment cabin (1) having closed walls, a closed roof and a door for entering the treatment cabin (1); a cold treatment gas preparation and distribution system for preparing a cold gas mixture and introducing it into the treatment cabin (1); and a control system (4) for controlling the introduction of cold treatment gas from the cold treatment gas preparation and distribution system into the treatment cabin (1), wherein the treatment cabin (1) further comprises a breathing window (7) for allowing a patient located inside the treatment cabin (1) to breath air from outside of the treatment cabin (1), the breathing window (7) comprising sealing means for allowing a tight contact between the breathing window (7) and the face of the patient.
WO/2014/086156 INSULATING METHOD FOR ALUMINUM BACK PLATE OF PHOTOVOLTAIC MODULE||WO||12.06.2014|
||PCT/CN2013/080126||HANWHA SOLARONE (QIDONG) CO., LTD||GAO, Yuanzhun|
An insulating method for aluminum back plate of a photovoltaic module comprises cutting an aluminum back plate (2) so that the size of each aluminum back plate is 4-5 mm smaller than the size of glass; opening a square hole at the portion of an electrode lead (4) of the aluminum back plate; when modules are arranged and laid, performing insulating treatment on the square opening (3) by adding insulating small materials or covering the edge with an insulating film; performing lamination and cutting an edge of a laminated piece, and covering, by using a 0.5-1mm insulated rubber tape, the edge of the laminated piece, of which the edge is cut; and finally spraying silica gel (6) on the laminated piece, framing up the laminated piece, and mounting a terminal box on the laminated piece. This method is easy to operate, requires low investment, and has a prospect of being widely applied.
WO/2014/084878 SENSOR FUSION ALGORITHM||WO||05.06.2014|
||PCT/US2013/028488||MICROSOFT CORPORATION||PEREK, David R.|
Sensor fusion algorithm techniques are described. In one or more embodiments, behaviors of a host device and accessory devices are controlled based upon an orientation of the host device and accessory devices, relative to one another. A combined spatial position and/or orientation for the host device may be obtained based on raw measurements that are obtained from at least two different types of sensors. In addition, a spatial position and/or orientation for an accessory device is ascertained using one or more sensors of the accessory device. An orientation (or position) of the accessory device relative to the host computing device may then be computed based on the combined spatial position/orientation for the host computing device and the ascertained spatial position/orientation for the accessory device. The relative orientation that is computed may then be used in various ways to control behaviors of the host computing device and/or accessory device.
WO/2014/082286 RAPAMYCIN ANALOGS AND METHODS FOR MAKING SAME||WO||05.06.2014|
||PCT/CN2012/085631||HANGZHOU ZYLOX PHARMA CO., LTD.||WANG, Bing|
A semi-synthetic rapamycin analog with a triazole moiety or a pharmaceutically acceptable salt or prodrug thereof, is a broad-spectrum cytostatic agent and a m TOR inhibitor, and is useful in the treatment of various cancers, or tumors in organs such as kidney, liver, breast, head and neck, lung, prostate, and restenosis in coronary arteries, peripheral arteries, and arteries in the brain, immune and autoimmune diseases. Also disclosed are fungal growth-, restenosis-, post- transplant tissue rejection- and immune- and autoimmune disease- inhibiting compositions and a method of inhibiting cancer, fungal growth, restenosois, post-transplant tissue rejection, and immune and autoimmune disease in a mammal. One particular preferred application of such triazole-moiety containing rapamycin analog is in treating renal carcinoma, lung cancer, colon cancer, and breast cancers wherein potency of the drug, its half-life, tissue distribution properties, and its pharmacokinetic properties including bioavailability through oral and intravenous routes are essential to the clinical outcomes.
WO/2014/079020 PHARMACEUTICAL COMPOSITION USED FOR REDUCING DAMAGE CAUSED BY FREE RADICALS||WO||30.05.2014|
||PCT/CN2012/085066||ORIGINAL BIOMEDICALS CO., LTD.||CHEN, Chia-Hung|
A pharmaceutical composition used for reducing the damage caused by free radicals is disclosed. The composition comprises at least a metal or its ions, at least a drug or an antioxidant that is carrier-protected/modified, and a drug carrier. Said carrier helps to preserve the anti-oxidative activity, and hence, prevents the decrease of the effect of the antioxidant against free radicals produced in the environment or body fluids and prolongs protection, and may be used for reducing damage caused by radiation and adverse effects induced by chemotherapeutic drugs.